| Literature DB >> 34935067 |
Christoph Bourauel1, Helmut Stark2, Istabrak Dörsam3,4, Anastasia Hombach5.
Abstract
OBJECTIVES: The aim of the study was to determine differences between Locator and CM LOC attachment systems regarding patient satisfaction and wear of the abutments and their inserts. Plaque accumulation onto the polyetherketoneketone (PEKK) framework and polymethylmethacrylate (PMMA) was investigated for the implant-supported overdentures.Entities:
Keywords: Attachment system; Overdenture; PEKK; Plaque accumulation; Wear
Mesh:
Substances:
Year: 2021 PMID: 34935067 PMCID: PMC8979906 DOI: 10.1007/s00784-021-04342-4
Source DB: PubMed Journal: Clin Oral Investig ISSN: 1432-6981 Impact factor: 3.573
Fig. 1Flowchart of the study protocol
Position of the overdenture, number, and position of the supporting implants for the patients involved in the study
| Patients | Position of the overdenture | Number of implants | Position of the implants | Implant system |
|---|---|---|---|---|
| 1 | Lower jaw | 4 | 34, 33, 43, 44 | Straumann RN |
| 2 | Lower jaw | 4 | 34, 32, 42, 44 | Straumann RN |
| 3 | Lower jaw | 4 | 34, 32, 42, 44 | Straumann BL |
| 4 | Lower jaw | 4 | 34, 32, 42, 44 | Straumann BL |
| 5 | Lower jaw | 4 | 34, 32, 42, 44 | Straumann RN/NCC |
| 6 | Lower jaw | 4 | 34, 32, 42, 44 | Straumann RN/NCC |
| 7 | Lower jaw | 4 | 33, 32, 42, 43 | Xive Densply |
| 8 | Lower jaw | 4 | 34, 32, 42, 44 | Brånemark |
| 9 | Lower jaw | 3 | 42, 32, 34 | Brånemark |
| 10 | Lower jaw | 2 | 33, 43 | Straumann RN |
| 11 | Lower jaw | 2 | 33, 43 | Straumann RN |
| 12 | Lower jaw | 2 | 33, 43 | Straumann BL |
| 13 | Lower jaw | 2 | 33, 43 | Straumann NCC |
| 14 | Lower jaw | 2 | 33, 43 | Astra Implants |
| 15 | Upper jaw | 4 | 23, 22, 13, 12 | Straumann RN |
| 16 | Upper jaw | 4 | 14, 12, 22, 24 | Straumann NCC |
| 17 | Upper jaw | 3 | 16, 15, 22 | Biomed |
Fig. 2Upper and lower overdentures with PEKK framework and PMMA facing. The star indicates the Position, where the plaque accumulation was taken for the evaluation of prosthesis plaque index
The three categories for the evaluation of OHIP questionnaire
| Question No | OHIP-14 questionnaire |
|---|---|
| Having difficulty pronouncing certain words? | |
| The feeling that your sense of taste was affected? | |
| The impression that your life in general was less satisfying | |
| Difficulties zu relax? | |
| Did you felt tensed up? | |
| Did you have to interrupt your meals? | |
| Were you uncomfortable eating certain foods? | |
| Have you been rather irritable towards other people? | |
| Did you find it difficult to perform your daily activities | |
| Were you completely unable to do anything? | |
| Did you feel a little embarrassed? | |
| Has your nutrition been dissatisfying? | |
| Pain in the Oral area? | |
| A feeling of uncertainty about your teeth, your mouth or your denture? | |
Fig. 3Exchange of the attachment system from CM LOC (upper photo) to Locator (lower photo) after 12 months
Fig. 4(a) Patient’s satisfaction, (b) and chewing ability and comfort, and (c) pressure lesions at the initial condition and after 6, 12, 18, and 24 months of receiving implant-supported overdenture
Fig. 5Examples of the prosthesis’s hygiene and plaque accumulation after 24 months of wearing the prosthesis without any professional cleaning and polishing during this period
Fig. 6(a) Regions of plaque accumulation on the Locator abutments. (b) Regions of plaque accumulation on the CM LOC abutments
Wear regions of the Locator and CM LOC systems after 12 months in mouth
| Patients | Position of the implant | Implant system | Diameter of the implant | Gingiva height of the abutment | Level of wear |
|---|---|---|---|---|---|
| 9 | 32 | Brånemark | 3.75 mm | 3 mm | Low |
| 42 | Brånemark | 3.75 mm | 2 mm | Middle | |
| 44 | Brånemark | 3.75 mm | 2 mm | Middle | |
| 11 | 33 | Straumann RN | 4.1 mm | 1 mm | Middle |
| 43 | Straumann RN | 4.1 mm | 1 mm | Middle | |
| 15 | 13 | Straumann RN | 4.8 mm | 1 mm | Middle |
| 12 | Straumann RN | 4.8 mm | 2 mm | Middle | |
| 22 | Straumann RN | 4.8 mm | 2 mm | Middle | |
| 23 | Straumann RN | 4.8 mm | 2 mm | Middle | |
| 2 | 34 distal | Straumann RN | 4.1 mm | 2 mm | Middle |
| 34 mesial | Middle | ||||
| 32 lingual | 4.1 mm | 2 mm | Middle | ||
| 32 labial | Middle | ||||
| 42 mesial | 4.1 mm | 2 mm | Middle | ||
| 42 distal | Middle | ||||
| 44 distal | 4.1 mm | 2 mm | Middle | ||
| 44 mesial | Middle | ||||
| 3 | 34 buccal | Straumann BL | 4.1 mm | 5 mm | Middle |
| 34 lingual | High | ||||
| 32 mesial | 4.1 mm | 4 mm | High | ||
| 32 distal | Middle | ||||
| 42 labial | 4.1 mm | 3 mm | Middle | ||
| 42 lingual | Middle | ||||
| 44 mesial | 4.1 mm | 4 mm | High | ||
| 44 distal | High | ||||
| 5 | 34 distal | Straumann RN | 4.1 mm | 1 mm | Middle |
| 34 mesial | Middle | ||||
| 32 mesial | Straumann NCC | 3.3 mm | 4 mm | Low | |
| 32 labial | Low | ||||
| 42 labial | Straumann NCC | 3.3 mm | 4 mm | High | |
| 42 lingual | High | ||||
| 44 mesial | Straumann RN | 4.1 mm | 1 mm | Middle | |
| 44 distal | Middle | ||||
| 6 | 32 lingual | Straumann NCC | 3.3 mm | 1 mm | Middle |
| 32 labial | High | ||||
| 42 distal | Straumann NCC | 3.3 mm | 1 mm | High | |
| 42 lingual | Middle | ||||
| 44 lingual | Straumann RN/ | 4.1 mm | 1 mm | Low | |
| 44 labial | Low | ||||
| 34 mesial | Straumann RN | 4.1 mm | 1 mm | Middle | |
| 34 buccal | Middle | ||||
| 9 | 32 labial | Brånemark | 3.75 mm | 1 mm | Low |
| 32 lingual | 1 mm | Low | |||
| 34 lingual | 3.75 mm | High | |||
| 34 buccal | High | ||||
| 42 mesial | 3.75 mm | 2 mm | Middle | ||
| 42 distal | Middle | ||||
| 44 mesial | 3.75 mm | 1 mm | Middle | ||
| 44 distal | Middle | ||||
| 4 | 34 distal | Straumann BL | 4.1 mm | 4 mm | Middle |
| 44 distal | 4.8 mm | 5 mm | Middle | ||
| 17 | 16 distal | Biomed | 4.1 mm | 0.73 mm | Middle |
| 16 buccal | Low | ||||
| 15 mesial | Biomed | 4.1 mm | 4 mm | Low | |
| 15 palatal | Low | ||||
| 22 palatal | Biomed | 5.0 mm | 4 mm | Middle | |
| 22 distal | Middle | ||||
Fig. 7Wear regions of the Locator abutments after 12 months of use intraorally
Fig. 8Wear regions of the CM LOC abutments after 12 months of use intraorally